We are live on ! Find out more
ECM

ETrade Capital Management Portfolio holdings

AUM $5.37B
1-Year Est. Return 10.84%
This Fund
S&P 500
This Quarter Est. Return
+3.13%
1 Year Est. Return
+10.84%
3 Year Est. Return
+26.27%
5 Year Est. Return
+59.01%
10 Year Est. Return
AUM
$3.72B
AUM Growth
+$232M
Cap. Flow
+$133M
Cap. Flow %
3.59%
Top 10 Hldgs %
50.29%
Holding
867
New
79
Increased
410
Reduced
295
Closed
83

Sector Composition

Rank Sector Weight
1 Technology 5.3%
2 Healthcare 4.45%
3 Financials 4.41%
4 Industrials 2.98%
5 Consumer Discretionary 2.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFX icon
226
Equifax
EFX
$20.3B
$1.8M 0.05%
13,311
+1,751
+15% +$220K
VOD icon
227
Vodafone
VOD
$36.3B
$1.8M 0.05%
110,129
-8,229
-7% -$142K
ON icon
228
ON Semiconductor
ON
$31.8B
$1.79M 0.05%
88,671
-2,508
-3% -$51.8K
LGND icon
229
Ligand Pharmaceuticals
LGND
$5.76B
$1.78M 0.05%
25,023
+960
+4% +$70.7K
BBL
230
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$1.78M 0.05%
34,854
-452
-1% -$21.6K
MPC icon
231
Marathon Petroleum
MPC
$92.4B
$1.77M 0.05%
31,719
+8,441
+36% +$462K
CHTR icon
232
Charter Communications
CHTR
$17.3B
$1.77M 0.05%
4,478
+3,278
+273% +$1.23M
INFO
233
DELISTED
IHS Markit Ltd. Common Shares
INFO
$1.76M 0.05%
27,564
+1,192
+5% +$68.4K
AEE icon
234
Ameren
AEE
$30.3B
$1.73M 0.05%
23,077
+2,963
+15% +$219K
ALXN
235
DELISTED
Alexion Pharmaceuticals
ALXN
$1.73M 0.05%
13,178
-2,013
-13% -$259K
NVCR icon
236
NovoCure
NVCR
$1.73B
$1.73M 0.05%
27,287
+5,957
+28% +$302K
PPLI
237
People Inc
PPLI
$3.09B
$1.72M 0.05%
44,310
-1,774
-4% -$70.8K
TOL icon
238
Toll Brothers
TOL
$13.6B
$1.71M 0.05%
46,683
+11,360
+32% +$424K
MPT
239
Medical Properties Trust
MPT
$2.77B
$1.68M 0.05%
96,378
-5,871
-6% -$106K
LULU icon
240
lululemon athletica
LULU
$13.5B
$1.66M 0.04%
9,206
+1,903
+26% +$331K
LYV icon
241
Live Nation Entertainment
LYV
$40.6B
$1.66M 0.04%
25,043
+2,789
+13% +$179K
FTNT icon
242
Fortinet
FTNT
$119B
$1.65M 0.04%
107,640
+43,650
+68% +$719K
ELV icon
243
Elevance Health
ELV
$81.5B
$1.65M 0.04%
5,854
+808
+16% +$221K
INFY icon
244
Infosys
INFY
$48.7B
$1.64M 0.04%
153,012
+40,179
+36% +$426K
DRE
245
DELISTED
Duke Realty Corp.
DRE
$1.63M 0.04%
51,397
+1,627
+3% +$50.3K
WST icon
246
West Pharmaceutical
WST
$24B
$1.61M 0.04%
12,872
+2,752
+27% +$325K
GWRE icon
247
Guidewire Software
GWRE
$12.6B
$1.6M 0.04%
+15,817
New +$1.61M
PLNT icon
248
Planet Fitness
PLNT
$4.42B
$1.59M 0.04%
22,008
+10,793
+96% +$813K
KEX icon
249
Kirby Corp
KEX
$7.01B
$1.58M 0.04%
19,966
+332
+2% +$26.6K
ANSS
250
DELISTED
Ansys
ANSS
$1.57M 0.04%
7,670
+482
+7% +$91.8K

Similar funds

ETrade Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, ETrade Capital Management held 867 positions worth $3.72B, up 6.7% from $3.48B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

ETrade Capital Management deployed $133M of net new capital in Q2 2019, opening 79 new positions and adding to 410 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 24,340 shares worth $7.17M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 5.3% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $10.3M trimmed.

  • ETrade Capital Management's largest Q2 2019 buy was iShares Core S&P 500 ETF: 24,340 shares worth $7.17M.
  • ETrade Capital Management added most to Vanguard Morningstar Value ETF in Q2 2019, an estimated $21.5M increase.
  • ETrade Capital Management's biggest Q2 2019 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $10.3M.
  • ETrade Capital Management fully exited DuPont de Nemours in Q2 2019, selling an estimated $4.04M.
  • ETrade Capital Management's ten largest holdings make up 50% of its $3.72B portfolio in Q2 2019.
  • ETrade Capital Management opened 79 new positions and closed 83 in Q2 2019.
  • ETrade Capital Management's portfolio value rose 6.7% quarter-over-quarter to $3.72B.

Based on ETrade Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.